227 related articles for article (PubMed ID: 1702300)
1. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.
Nakamura GR; Byrn R; Rosenthal K; Porter JP; Hobbs MR; Riddle L; Eastman DJ; Dowbenko D; Gregory T; Fendly BM
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1875-85. PubMed ID: 1283308
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416
[TBL] [Abstract][Full Text] [Related]
4. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.
Dickey C; Ziegner U; Agadjanyan MG; Srikantan V; Refaeli Y; Prabhu A; Sato A; Williams WV; Weiner DB; Ugen KE
DNA Cell Biol; 2000 Apr; 19(4):243-52. PubMed ID: 10798448
[TBL] [Abstract][Full Text] [Related]
5. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
[TBL] [Abstract][Full Text] [Related]
8. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
[TBL] [Abstract][Full Text] [Related]
9. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
10. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
[TBL] [Abstract][Full Text] [Related]
11. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
[TBL] [Abstract][Full Text] [Related]
12. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
13. Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induces both class I- and class II-restricted T cells: not all T cells can respond to whole molecule stimulation.
Moore RL; Fox BS
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):51-9. PubMed ID: 7678972
[TBL] [Abstract][Full Text] [Related]
14. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
[TBL] [Abstract][Full Text] [Related]
15. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
Rodriguez D; Rodriguez JR; Esteban M
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
[TBL] [Abstract][Full Text] [Related]
16. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
[TBL] [Abstract][Full Text] [Related]
17. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
Stamatatos L; Lim M; Cheng-Mayer C
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen.
VanCott TC; Veit SC; Kalyanaraman V; Earl P; Birx DL
J Immunol Methods; 1995 Jun; 183(1):103-17. PubMed ID: 7602128
[TBL] [Abstract][Full Text] [Related]
19. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
[TBL] [Abstract][Full Text] [Related]
20. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
